Telix Pharmaceuticals | TLX - Assets

Stock Price
10.00
Daily Change
-0.20 -1.96%
Monthly
-14.16%
Yearly
-64.86%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD1.16B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Cochlear AUD 2.82B 38.9M Jun/2025
CSL USD 39.4B 957M Jun/2025
Integral Diagnostics AUD 744.28M 1.52M Jun/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Medical Developments International AUD 66.4M 1.06M Jun/2025
Mesoblast USD 784.68M 131.36M Jun/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Pacific Edge NZD 34.66M 2.37M Dec/2025
Paradigm Biopharmaceuticals AUD 24.57M 10.79M Jun/2025
Polynovo AUD 108.72M 11.51M Jun/2024
PYC Therapeutics AUD 183.28M 115.05M Jun/2025
Ramsay Health Care AUD 22.48B 1.82B Jun/2025
ResMed USD 8.5B 195.02M Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024